Click boxes below for more information
Click boxes below for more information
Click boxes below for more information
Click boxes below for more information
Philips supports healthcare providers meet their clinical, operational and financial objectives in oncology by providing access to a range of Strategic Partnership solutions designed to deliver value based healthcare. Tumour characterisation, sub-typing and staging are becoming more complex and mission critical. There is need to identify cancers more efficiently through faster, more accurate diagnosis and facilitating clinical decisions to treat and deliver optimal treatment therapies.
Partnering with healthcare providers to transform Oncology diagnostics services, through facilitating access to a range of innovative solutions:
Partnering to enable better clinical decisions through integrated multi-disciplinary team (MDT) Tumour assessment:
Partnering to enable better clinical decisions through integrated multi-disciplinary team (MDT) Tumour assessment:
Partnering with healthcare providers to revolutionise Oncology services through assessing equipment needs, improving patient and staff satisfaction, designing and delivering state-of-the-art facilities.
Philips in-house facility planning and design department work in partnership to provide:
Philips integrated approach delivers lower total cost of ownership and predictable payment structures which empower customers to enhance patient experiences and lower cost of care.
Partnering to achieve flexible financial engineering investment plans which provide cost predictability and certainty.
Financial engineering solutions include:
Or more traditional
Philips understands the unique opportunity we have to bring more to our community, and I’m confident that their wealth of experience and international expertise will help us collaboratively make changes that are focussed on helping our patients and team members”
Robert Griffiths, Radiology Services Manager
Wye Valley NHS Trust
Partnering on transformation of Oncology services, we deliver:
1. World Economic Forum and the Harvard School of Public Health. The Global Economic Burden of Non-communicable Diseases. September 2011. https://.www3.weforum.org/docs/WEF_Harvard_HE_GlobalEconomicBurdenNonCommunicableDiseases_2011.pdf https://.www.iarc.fr/en/media-centre/pr/2014/pdfs/pr224_E.pdf
2. GloboCan/ International Agency for Research on Cancer. PR No 224. 3 February 2014.
You are about to visit a Philips global content page
Continue